HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brett King Selected Research

Aftercare (After-Treatment)

2/2009Palifermin-associated papular eruption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brett King Research Topics

Disease

18Alopecia Areata
01/2024 - 10/2019
8Alopecia (Baldness)
12/2023 - 01/2021
7Sarcoidosis (Schaumann Disease)
01/2022 - 12/2018
4Hepatocellular Carcinoma (Hepatoma)
07/2023 - 01/2022
3Acne Vulgaris
10/2023 - 01/2022
3COVID-19
05/2023 - 01/2020
3Atopic Dermatitis (Atopic Eczema)
05/2021 - 09/2020
3Granuloma Annulare
01/2021 - 01/2020
2Respiratory Tract Infections (Respiratory Tract Infection)
10/2023 - 05/2023
2Nasopharyngitis
10/2023 - 05/2023
2Headache (Headaches)
10/2023 - 05/2023
2Infections
05/2023 - 05/2021
2Vitiligo
01/2023 - 07/2022
2Neoplasms (Cancer)
05/2021 - 11/2014
2Inflammation (Inflammations)
01/2021 - 02/2020
2Necrobiosis Lipoidica
02/2020 - 01/2020
2Lichen Planus (Lichen Ruber Planus)
01/2020 - 02/2009
2Melanoma (Melanoma, Malignant)
10/2015 - 11/2014
2Neoplasm Metastasis (Metastasis)
10/2015 - 11/2014
1Urinary Tract Infections (Urinary Tract Infection)
05/2023
1Carcinoma (Carcinomatosis)
01/2023
1Erythema Multiforme
12/2021
1Dermatitis
10/2021
1Herpes Simplex
05/2021
1Opportunistic Infections (Opportunistic Infection)
05/2021
1Bullous Pemphigoid (Pemphigoid)
07/2020
1Localized Scleroderma (Morphea)
01/2020
1Chilblains (Chilblain)
01/2020
1Crohn Disease (Crohn's Disease)
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Granuloma
01/2020
1Hypersensitivity (Allergy)
12/2019
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
01/2017
1digital ulcers
01/2015
1Enterovirus Infections
11/2013
1Exanthema (Rash)
02/2009
1Pruritus (Itching)
02/2009
1Warts (Wart)
02/2009
1Stomatitis
02/2009
1Erythema
02/2009

Drug/Important Bio-Agent (IBA)

15Janus Kinase InhibitorsIBA
05/2023 - 01/2017
14Janus KinasesIBA
10/2023 - 12/2018
11tofacitinibIBA
11/2022 - 01/2017
10baricitinibIBA
12/2023 - 10/2019
8SaltsIBA
12/2023 - 01/2021
5CytokinesIBA
01/2022 - 01/2020
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2023 - 01/2022
3Phosphotransferases (Kinase)IBA
01/2024 - 01/2023
3frovatriptan (Allegro)FDA Link
01/2024 - 11/2022
3Creatine Kinase (Creatine Phosphokinase)IBA
10/2023 - 01/2022
3GlucocorticoidsIBA
01/2022 - 12/2018
2Tec protein-tyrosine kinaseIBA
01/2023 - 01/2022
2TYK2 Kinase (Tyrosine Kinase 2)IBA
11/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2020
2Interleukin-15 (Interleukin 15)IBA
12/2021 - 01/2021
2dupilumabIBA
01/2021 - 07/2020
2Interleukin-2 (IL2)IBA
10/2015 - 11/2014
1Minoxidil (Rogaine)FDA LinkGeneric
11/2022
1Coenzyme A (CoA)IBA
07/2022
1HDL CholesterolIBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
12/2021
1Janus Kinase 1IBA
05/2021
1Janus Kinase 2IBA
05/2021
1Ointments (Pastes)IBA
01/2021
1interleukin-21 (interleukin 21)IBA
01/2021
1Immunoglobulin A (IgA)IBA
09/2020
1Proteins (Proteins, Gene)FDA Link
03/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2020
1Methotrexate (Mexate)FDA LinkGeneric
02/2020
1Prednisone (Sone)FDA LinkGeneric
02/2020
1InterferonsIBA
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1RNA (Ribonucleic Acid)IBA
12/2018
1ruxolitinibIBA
01/2017
1RetinoidsIBA
10/2015
1Imiquimod (Aldara)FDA LinkGeneric
10/2015
1InterleukinsIBA
10/2015
1Valproic Acid (Depakote)FDA LinkGeneric
01/2015
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2013
1Melphalan (Alkeran)FDA LinkGeneric
02/2009
1Fibroblast Growth Factor 7FDA Link
02/2009

Therapy/Procedure

15Therapeutics
12/2023 - 02/2009
1Dye Lasers
01/2021
1Hematopoietic Stem Cell Transplantation
02/2009
1Aftercare (After-Treatment)
02/2009